The WACC of Inozyme Pharma Inc (INZY) is 8.6%.
| Range | Selected | |
| Cost of equity | 9.90% - 14.90% | 12.40% |
| Tax rate | 26.20% - 27.00% | 26.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 7.2% - 10.0% | 8.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.31 | 1.79 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 9.90% | 14.90% |
| Tax rate | 26.20% | 27.00% |
| Debt/Equity ratio | 0.78 | 0.78 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 7.2% | 10.0% |
| Selected WACC | 8.6% | |